The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction

Harry H Yoon, Val Lowe, Stephen D. Cassivi, Yvonne Romero

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The effort to improve outcomes in esophageal cancer has included attempts at improving staging and patient selection. 2-Deoxy-2-[ 18F]fluoro-Dglucose positron emission tomography (FDG-PET) has been extensively studied in this context and has been widely accepted as a staging tool. Its role in restaging or assessing therapeutic response is investigational and promising. Laparoscopy has also been studied as a means for improving staging, but its role may be limited in the era of PET. This article discusses the literature assessing these modalities, particularly with regard to the practical management of the patient in the clinic.

Original languageEnglish (US)
Pages (from-to)105-120
Number of pages16
JournalGastroenterology Clinics of North America
Volume38
Issue number1
DOIs
StatePublished - Mar 2009

Fingerprint

Esophagogastric Junction
Esophageal Neoplasms
Positron-Emission Tomography
Laparoscopy
Patient Selection
Therapeutics

Keywords

  • CT
  • Esophageal cancer
  • Gastroesophageal junction cancer
  • PET
  • Prognosis
  • Staging
  • Staging laparoscopy
  • Treatment response

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction. / Yoon, Harry H; Lowe, Val; Cassivi, Stephen D.; Romero, Yvonne.

In: Gastroenterology Clinics of North America, Vol. 38, No. 1, 03.2009, p. 105-120.

Research output: Contribution to journalArticle

@article{1f3e4e3e0f8948a5b166aa2a8b64e5a7,
title = "The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction",
abstract = "The effort to improve outcomes in esophageal cancer has included attempts at improving staging and patient selection. 2-Deoxy-2-[ 18F]fluoro-Dglucose positron emission tomography (FDG-PET) has been extensively studied in this context and has been widely accepted as a staging tool. Its role in restaging or assessing therapeutic response is investigational and promising. Laparoscopy has also been studied as a means for improving staging, but its role may be limited in the era of PET. This article discusses the literature assessing these modalities, particularly with regard to the practical management of the patient in the clinic.",
keywords = "CT, Esophageal cancer, Gastroesophageal junction cancer, PET, Prognosis, Staging, Staging laparoscopy, Treatment response",
author = "Yoon, {Harry H} and Val Lowe and Cassivi, {Stephen D.} and Yvonne Romero",
year = "2009",
month = "3",
doi = "10.1016/j.gtc.2009.01.007",
language = "English (US)",
volume = "38",
pages = "105--120",
journal = "Gastroenterology Clinics of North America",
issn = "0889-8553",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction

AU - Yoon, Harry H

AU - Lowe, Val

AU - Cassivi, Stephen D.

AU - Romero, Yvonne

PY - 2009/3

Y1 - 2009/3

N2 - The effort to improve outcomes in esophageal cancer has included attempts at improving staging and patient selection. 2-Deoxy-2-[ 18F]fluoro-Dglucose positron emission tomography (FDG-PET) has been extensively studied in this context and has been widely accepted as a staging tool. Its role in restaging or assessing therapeutic response is investigational and promising. Laparoscopy has also been studied as a means for improving staging, but its role may be limited in the era of PET. This article discusses the literature assessing these modalities, particularly with regard to the practical management of the patient in the clinic.

AB - The effort to improve outcomes in esophageal cancer has included attempts at improving staging and patient selection. 2-Deoxy-2-[ 18F]fluoro-Dglucose positron emission tomography (FDG-PET) has been extensively studied in this context and has been widely accepted as a staging tool. Its role in restaging or assessing therapeutic response is investigational and promising. Laparoscopy has also been studied as a means for improving staging, but its role may be limited in the era of PET. This article discusses the literature assessing these modalities, particularly with regard to the practical management of the patient in the clinic.

KW - CT

KW - Esophageal cancer

KW - Gastroesophageal junction cancer

KW - PET

KW - Prognosis

KW - Staging

KW - Staging laparoscopy

KW - Treatment response

UR - http://www.scopus.com/inward/record.url?scp=62749194562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62749194562&partnerID=8YFLogxK

U2 - 10.1016/j.gtc.2009.01.007

DO - 10.1016/j.gtc.2009.01.007

M3 - Article

VL - 38

SP - 105

EP - 120

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

SN - 0889-8553

IS - 1

ER -